MedKoo Cat#: 526608 | Name: GYKI-53405

Description:

WARNING: This product is for research use only, not for human or veterinary use.

GYKI-53405, also known as LY 293606, is a noncompetitive AMPA receptor antagonist. GYKI-53405 binds specifically to Xenopus brain membranes with KD and Bmax values of 4.5 microM and 35 pmol mg-1 protein respectively. Binding is increased in the presence of Mg2+ and is unaffected by AMPA or kainate.

Chemical Structure

GYKI-53405
GYKI-53405
CAS#143691-37-6

Theoretical Analysis

MedKoo Cat#: 526608

Name: GYKI-53405

CAS#: 143691-37-6

Chemical Formula: C19H19N3O3

Exact Mass: 337.1426

Molecular Weight: 337.38

Elemental Analysis: C, 67.64; H, 5.68; N, 12.46; O, 14.23

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
GYKI-53405; GYKI 53405; GYKI53405; LY 293606; LY-293606; LY293606;
IUPAC/Chemical Name
1-(4-Aminophenyl)-3-acetyl-4-methyl-3,4-dihydro-7,8-methylenedioxy-5H-2,3-benzodiazepine
InChi Key
JACAAXNEHGBPOQ-UHFFFAOYSA-N
InChi Code
InChI=1S/C19H19N3O3/c1-11-7-14-8-17-18(25-10-24-17)9-16(14)19(21-22(11)12(2)23)13-3-5-15(20)6-4-13/h3-6,8-9,11H,7,10,20H2,1-2H3
SMILES Code
CC1N(C(C)=O)N=C(C2=CC=C(N)C=C2)C3=CC4=C(OCO4)C=C3C1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 337.38 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Jakus R, Graf M, Ando RD, Balogh B, Gacsalyi I, Levay G, Kantor S, Bagdy G. Effect of two noncompetitive AMPA receptor antagonists GYKI 52466 and GYKI 53405 on vigilance, behavior and spike-wave discharges in a genetic rat model of absence epilepsy. Brain Res. 2004 May 22;1008(2):236-44. PubMed PMID: 15145761. 2: Szabados T, Gigler G, Gacsályi I, Gyertyán I, Lévay G. Comparison of anticonvulsive and acute neuroprotective activity of three 2,3-benzodiazepine compounds, GYKI 52466, GYKI 53405, and GYKI 53655. Brain Res Bull. 2001 Jun;55(3):387-91. PubMed PMID: 11489346. 3: Szabó G, Henley JM. Binding of the AMPA receptor antagonist [3H]GYKI 53405 to Xenopus brain membranes. Neuroreport. 1993 Oct 25;5(1):93-4. PubMed PMID: 7506593.